Multiply Labs raises $75M Series B led by NantWorks for robots that automate drug manufacturing
Partly confirmed
The takeaway
On Oct 6, 2026 the San Francisco startup Multiply Labs announced a $75 million Series B led by Patrick Soon-Shiong’s NantWorks, with AstraZeneca, Lingotto, Teradyne and Strange Ventures as new investors.
Status
- Claim
Partly confirmed
- Our reporting
- Medium confidence
- Importance
- 2 of 5
- Last verified
- 12 October 2026
Your AI and this story
- GPT-6 Astra159 days after its cutoff
- Claude Opus 5.598 days after its cutoff
- Gemini 3.8 Flash189 days after its cutoff
- Grok 4.7128 days after its cutoff
None of these four assistants can know about it. The closest, Claude Opus 5.5, stops 98 days before it.
Key facts
- $75M Series B led by Dr. Patrick Soon-Shiong and NantWorks; new investors AstraZeneca, Lingotto, Teradyne, Strange Ventures; returning: Casdin Capital, Lux Capital, Fifty Years, Ora Global, Founders Fund
- Total funding of more than $100M since its founding in 2016
- Company claims: its robotic clusters work with existing pharmaceutical equipment, cut cost per dose by 74% and deliver up to 100 times the throughput of manual manufacturing (not independently verified)
- Covers cell and gene therapies, antibodies, viral vectors and mRNA therapies; the company is moving from clinical-stage deployments toward commercial production
What happened
Multiply Labs said it will use the money to expand manufacturing capacity, speed up product development and grow its engineering, regulatory and commercial teams. Its argument is that AI has sped up drug discovery while manufacturing of advanced therapies is still largely manual, slow and exposed to contamination. Written from trade-press reports of the company’s announcement.
Why it matters
It is one of the larger 2026 rounds for robots in a regulated industrial setting, with a drug maker (AstraZeneca) and a robotics supplier (Teradyne) among the investors.
Sources
2 sources from 2 sites. Numbers match the chips in the text.
2 sources: 2 press
Press
- AI Insider: Multiply Labs Raises $75M in Series B Funding to Expand Robotic Drug Manufacturingtheaiinsider.tech, press
- MobiHealthNews: Multiply Labs raises $75M for manufacturing roboticsmobihealthnews.com, press
Changes
- Filed from a lead (evening)